VOLITIONRX LTD — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
▼ Likely negative
significance 72/100
What the filing says
VolitionRx (VNRX) reached a waiver agreement with Lind Global Asset Management XII LLC on May 21, 2026, waiving a market-capitalization default triggered on May 8, 2026 under two convertible notes totaling $9.9M principal ($7.5M + $2.4M). The default occurred because market cap fell below $22.5M for ten consecutive trading days. Lind waived acceleration and foreclosure remedies but retained a triggered conversion right at 90% of 20-day VWAP floor. Company also adopted a new 2026 Stock Incentive Plan with 850,000 shares reserved, enabling grants of options, RSUs, restricted stock, and performance shares to employees, directors, and consultants.
Why this rating
Default waiver avoids immediate refinancing crisis but dilution risk remains. Combined debt + equity plan at $72.9M market cap = material refinancing/dilution pressure.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.